pamrevlumab
Showing 1 - 5 of 5
COVID-19 Respiratory Infection, COVID-19 Pneumonia, Covid19 Trial in Rome (Pamrevlumab)
Completed
- COVID-19 Respiratory Infection
- +2 more
- Pamrevlumab
-
Rome, Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Mar 1, 2022
Duchenne Muscular Dystrophy Trial in United States (Pamrevlumab)
Active, not recruiting
- Duchenne Muscular Dystrophy
- Pamrevlumab
-
Los Angeles, California
- +9 more
Nov 30, 2021
Duchenne Muscular Dystrophy Trial in Worldwide (Pamrevlumab, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- Pamrevlumab
- Placebo
-
Little Rock, Arkansas
- +46 more
Apr 11, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Pamrevlumab, Placebo)
Active, not recruiting
- Duchenne Muscular Dystrophy
- Pamrevlumab
- Placebo
-
Little Rock, Arkansas
- +52 more
Jan 21, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (Pamrevlumab, Placebo, Sub-Study: Pirfenidone)
Completed
- Idiopathic Pulmonary Fibrosis
- Pamrevlumab
- +3 more
-
Birmingham, Alabama
- +41 more
Aug 19, 2020